• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有 Fic 折叠结构的腺苷转移酶的保守抑制机制和有效的 ATP 结合模式。

Conserved inhibitory mechanism and competent ATP binding mode for adenylyltransferases with Fic fold.

机构信息

Focal Area Infection Biology, Biozentrum, University of Basel, Basel, Switzerland.

出版信息

PLoS One. 2013 May 30;8(5):e64901. doi: 10.1371/journal.pone.0064901. Print 2013.

DOI:10.1371/journal.pone.0064901
PMID:23738009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3667792/
Abstract

The ubiquitous FIC domain is evolutionarily conserved from bacteria to human and has been shown to catalyze AMP transfer onto protein side-chain hydroxyl groups. Recently, it was predicted that most catalytically competent Fic proteins are inhibited by the presence of an inhibitory helix αinh that is provided by a cognate anti-toxin (class I), or is part of the N- or C-terminal part of the Fic protein itself (classes II and III). In vitro, inhibition is relieved by mutation of a conserved glutamate of αinh to glycine. For the class III bacterial Fic protein NmFic from Neisseria meningitidis, the inhibitory mechanism has been elucidated. Here, we extend above study by including bacterial class I and II Fic proteins VbhT from Bartonella schoenbuchensis and SoFic from Shewanella oneidensis, respectively, and the respective E->G mutants. Comparative enzymatic and crystallographic analyses show that, in all three classes, the ATP substrate binds to the wild-type FIC domains, but with the α-phosphate in disparate and non-competent orientations. In the E->G mutants, however, the tri-phosphate moiety is found reorganized to the same tightly bound structure through a unique set of hydrogen bonds with Fic signature motif residues. The γ-phosphate adopts the location that is taken by the inhibitory glutamate in wild-type resulting in an α-phosphate orientation that can be attacked in-line by a target side-chain hydroxyl group. The latter is properly registered to the Fic active center by main-chain β-interactions with the β-hairpin flap. These data indicate that the active site motif and the exposed edge of the flap are both required to form an adenylylation-competent Fic protein.

摘要

普遍存在的 FIC 结构域在从细菌到人等生物中都具有进化保守性,并且已被证明可催化 AMP 转移到蛋白质侧链羟基上。最近,有人预测,大多数具有催化能力的 Fic 蛋白都受到抑制性αinh 螺旋的抑制,该螺旋由同源的抗毒素(I 类)提供,或者是 Fic 蛋白自身的 N 端或 C 端的一部分(II 类和 III 类)。在体外,通过突变αinh 中保守的谷氨酸为甘氨酸可以解除抑制。对于脑膜炎奈瑟菌的 III 类细菌 Fic 蛋白 NmFic,已阐明了其抑制机制。在这里,我们通过包括来自巴尔通体属的 Bartonella schoenbuchensis 的 VbhT 和来自希瓦氏菌属的 Shewanella oneidensis 的 SoFic 以及各自的 E->G 突变体,扩展了上述研究。比较酶学和晶体学分析表明,在所有三类 FIC 结构域中,ATP 底物都与野生型 FIC 结构域结合,但α-磷酸的位置不同且不具有竞争能力。然而,在 E->G 突变体中,三磷酸部分通过与 Fic 特征基序残基形成独特的氢键重新组织成相同的紧密结合结构。γ-磷酸占据了野生型中抑制性谷氨酸的位置,从而使α-磷酸的取向可以通过靶标侧链羟基的直线进攻。后者通过与β发夹瓣的主链β-相互作用,正确地注册到 Fic 活性中心,从而实现腺苷酰化的活性。这些数据表明,活性位点基序和瓣的暴露边缘都需要形成具有腺苷酰化能力的 Fic 蛋白。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fbc/3667792/a28fdcf8ef39/pone.0064901.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fbc/3667792/0473ff90116d/pone.0064901.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fbc/3667792/1cd45144228d/pone.0064901.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fbc/3667792/656a96feb714/pone.0064901.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fbc/3667792/fd1f90eaf917/pone.0064901.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fbc/3667792/a28fdcf8ef39/pone.0064901.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fbc/3667792/0473ff90116d/pone.0064901.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fbc/3667792/1cd45144228d/pone.0064901.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fbc/3667792/656a96feb714/pone.0064901.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fbc/3667792/fd1f90eaf917/pone.0064901.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fbc/3667792/a28fdcf8ef39/pone.0064901.g005.jpg

相似文献

1
Conserved inhibitory mechanism and competent ATP binding mode for adenylyltransferases with Fic fold.具有 Fic 折叠结构的腺苷转移酶的保守抑制机制和有效的 ATP 结合模式。
PLoS One. 2013 May 30;8(5):e64901. doi: 10.1371/journal.pone.0064901. Print 2013.
2
Adenylylation control by intra- or intermolecular active-site obstruction in Fic proteins.Fic 蛋白通过活性部位的分子内或分子间阻碍作用进行腺苷酰化控制。
Nature. 2012 Jan 22;482(7383):107-10. doi: 10.1038/nature10729.
3
A Novel Fic (Filamentation Induced by cAMP) Protein from Clostridium difficile Reveals an Inhibitory Motif-independent Adenylylation/AMPylation Mechanism.一种来自艰难梭菌的新型Fic(cAMP诱导的丝状化)蛋白揭示了一种不依赖抑制基序的腺苷酸化/AMP化机制。
J Biol Chem. 2016 Jun 17;291(25):13286-300. doi: 10.1074/jbc.M115.705491. Epub 2016 Apr 13.
4
Intrinsic regulation of FIC-domain AMP-transferases by oligomerization and automodification.FIC结构域AMP转移酶通过寡聚化和自身修饰的内在调控
Proc Natl Acad Sci U S A. 2016 Feb 2;113(5):E529-37. doi: 10.1073/pnas.1516930113. Epub 2016 Jan 19.
5
Evolutionary Diversification of Host-Targeted Effectors Proteins Derived from a Conserved FicTA Toxin-Antitoxin Module.源自保守FicTA毒素-抗毒素模块的宿主靶向效应蛋白的进化多样化
Microorganisms. 2021 Jul 31;9(8):1645. doi: 10.3390/microorganisms9081645.
6
Fic domain-catalyzed adenylylation: insight provided by the structural analysis of the type IV secretion system effector BepA.Fic 结构域催化的腺苷酰化作用:通过 IV 型分泌系统效应蛋白 BepA 的结构分析提供的见解。
Protein Sci. 2011 Mar;20(3):492-9. doi: 10.1002/pro.581. Epub 2011 Feb 17.
7
Deciphering the Molecular Basis of Functional Divergence in AMPylating Enzymes by Molecular Dynamics Simulations and Structure Guided Phylogeny.通过分子动力学模拟和结构导向系统发育分析解析腺苷化酶功能分化的分子基础
Biochemistry. 2015 Aug 25;54(33):5209-24. doi: 10.1021/acs.biochem.5b00351. Epub 2015 Aug 14.
8
Crystal Structure of the Escherichia coli Fic Toxin-Like Protein in Complex with Its Cognate Antitoxin.大肠杆菌Fic毒素样蛋白与其同源抗毒素复合物的晶体结构
PLoS One. 2016 Sep 22;11(9):e0163654. doi: 10.1371/journal.pone.0163654. eCollection 2016.
9
Comparative analysis of Histophilus somni immunoglobulin-binding protein A (IbpA) with other fic domain-containing enzymes reveals differences in substrate and nucleotide specificities.比较分析唾液链球菌Histophilus somni 免疫球蛋白结合蛋白 A(IbpA)与其他 fic 结构域含酶,揭示了在底物和核苷酸特异性方面的差异。
J Biol Chem. 2011 Sep 16;286(37):32834-42. doi: 10.1074/jbc.M111.227603. Epub 2011 Jul 27.
10
The fic domain: regulation of cell signaling by adenylylation.Fic结构域:腺苷酸化对细胞信号传导的调控
Mol Cell. 2009 Apr 10;34(1):93-103. doi: 10.1016/j.molcel.2009.03.008.

引用本文的文献

1
Structural Insights into the Regulatory Mechanisms of the Toxic Activity of Sofic in Anti-Phage Defense Systems.关于索非奇在抗噬菌体防御系统中毒性活性调控机制的结构见解
Int J Mol Sci. 2025 Jun 24;26(13):6074. doi: 10.3390/ijms26136074.
2
The rise of AMPylation: from bacterial beginnings to modern implications in health and disease.腺苷酸化的兴起:从细菌起源到对健康与疾病的现代影响
Biochem Soc Trans. 2025 Aug 29;53(4):763-774. doi: 10.1042/BST20253056.
3
The DNA-binding induced (de)AMPylation activity of a Coxiella burnetii Fic enzyme targets Histone H3.

本文引用的文献

1
Adenylylation control by intra- or intermolecular active-site obstruction in Fic proteins.Fic 蛋白通过活性部位的分子内或分子间阻碍作用进行腺苷酰化控制。
Nature. 2012 Jan 22;482(7383):107-10. doi: 10.1038/nature10729.
2
Modulation of Rab GTPase function by a protein phosphocholine transferase.蛋白磷酸胆碱转移酶对 Rab GTPase 功能的调节。
Nature. 2011 Aug 7;477(7362):103-6. doi: 10.1038/nature10335.
3
Fic domain-catalyzed adenylylation: insight provided by the structural analysis of the type IV secretion system effector BepA.
贝氏考克斯体 Fic 酶的 DNA 结合诱导(去)腺苷酸化活性靶向组蛋白 H3。
Commun Biol. 2023 Nov 6;6(1):1124. doi: 10.1038/s42003-023-05494-7.
4
Catalytic deAMPylation in AMPylation-inhibitory/assistant forms of FICD protein.FICD蛋白的腺苷酸化抑制/辅助形式中的催化去腺苷酸化作用
Front Chem. 2023 Jan 25;11:1077188. doi: 10.3389/fchem.2023.1077188. eCollection 2023.
5
The Alarmone Diadenosine Tetraphosphate as a Cosubstrate for Protein AMPylation.作为蛋白 AMP 化反应辅助底物的双腺苷四磷酸警报素。
Angew Chem Int Ed Engl. 2023 Feb 13;62(8):e202213279. doi: 10.1002/anie.202213279. Epub 2023 Jan 16.
6
AMPylation and Endoplasmic Reticulum Protein Folding Homeostasis.腺苷酸化与内质网蛋白质折叠稳态
Cold Spring Harb Perspect Biol. 2023 Mar 1;15(3):a041265. doi: 10.1101/cshperspect.a041265.
7
Evolutionary Diversification of Host-Targeted Effectors Proteins Derived from a Conserved FicTA Toxin-Antitoxin Module.源自保守FicTA毒素-抗毒素模块的宿主靶向效应蛋白的进化多样化
Microorganisms. 2021 Jul 31;9(8):1645. doi: 10.3390/microorganisms9081645.
8
Structures of a deAMPylation complex rationalise the switch between antagonistic catalytic activities of FICD.去 AMP 化复合物的结构阐明了 FICD 拮抗催化活性之间的转换。
Nat Commun. 2021 Aug 18;12(1):5004. doi: 10.1038/s41467-021-25076-7.
9
Structural basis for selective AMPylation of Rac-subfamily GTPases by effector protein 1 (Bep1).效应蛋白 1(Bep1)选择性 AMP 化 Rac 亚家族 GTPases 的结构基础。
Proc Natl Acad Sci U S A. 2021 Mar 23;118(12). doi: 10.1073/pnas.2023245118.
10
An oligomeric state-dependent switch in the ER enzyme FICD regulates AMPylation and deAMPylation of BiP.FICD 在 ER 酶中的寡聚状态依赖性开关调节 BiP 的 AMPylation 和去 AMPylation。
EMBO J. 2019 Oct 4;38(21):e102177. doi: 10.15252/embj.2019102177. Epub 2019 Sep 18.
Fic 结构域催化的腺苷酰化作用:通过 IV 型分泌系统效应蛋白 BepA 的结构分析提供的见解。
Protein Sci. 2011 Mar;20(3):492-9. doi: 10.1002/pro.581. Epub 2011 Feb 17.
4
Structural basis of Fic-mediated adenylylation.Fic 介导的腺苷酸化的结构基础。
Nat Struct Mol Biol. 2010 Aug;17(8):1004-10. doi: 10.1038/nsmb.1867. Epub 2010 Jul 11.
5
Kinetic and structural insights into the mechanism of AMPylation by VopS Fic domain.VopS Fic 结构域对 AMP 化作用机制的动力学和结构研究
J Biol Chem. 2010 Jun 25;285(26):20155-63. doi: 10.1074/jbc.M110.114884. Epub 2010 Apr 21.
6
Features and development of Coot.Coot的特点与发展
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501. doi: 10.1107/S0907444910007493. Epub 2010 Mar 24.
7
PHENIX: a comprehensive Python-based system for macromolecular structure solution.PHENIX:一个基于Python的用于大分子结构解析的综合系统。
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21. doi: 10.1107/S0907444909052925. Epub 2010 Jan 22.
8
XDS.XDS.(这个词如果没有更多背景信息,很难准确翻译出更有意义的内容,直接保留原文是一种处理方式,或者音译为“克斯达斯”之类,但感觉都不太符合常规翻译场景,你可以补充更多关于这个词的信息以便我更准确翻译 )
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32. doi: 10.1107/S0907444909047337. Epub 2010 Jan 22.
9
MolProbity: all-atom structure validation for macromolecular crystallography.MolProbity:用于大分子晶体学的全原子结构验证
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21. doi: 10.1107/S0907444909042073. Epub 2009 Dec 21.
10
Fido, a novel AMPylation domain common to fic, doc, and AvrB.菲多,一种存在于fic、doc和AvrB中的新型腺苷酸化结构域。
PLoS One. 2009 Jun 5;4(6):e5818. doi: 10.1371/journal.pone.0005818.